Literature DB >> 8896193

A three-compartment open pharmacokinetic model can explain variable toxicities of cobra venoms and their alpha toxins.

M Ismail1, M H Aly, M A Abd-Elsalam, A M Morad.   

Abstract

The pharmacokinetic profiles of labelled Naja melanoleuca, Naja nivea, Naja nigricollis and Naja haje venoms and their alpha neurotoxins were determined following rapid i.v. injection into rabbits. The data obtained fitted a triexponential equation characteristic of a three-compartment open pharmacokinetic model comprising a central compartment 'blood', a rapidly equilibrating 'shallow' tissue compartment and a slowly equilibrating 'deep' tissue compartment. The distribution half-lives for the shallow compartment ranged from 3.2 to 5 min, reflecting the rapid uptake of venoms and toxins compared with 22-47 min for the deep tissue compartment denoting much slower uptake. The overall elimination half-lives, t1/2 beta, ranged from 15 to 29 hr, indicating a slow body elimination. Peak tissue concentration was reached within 15-20 min in the shallow tissue compartment. The corresponding values for the deep tissue compartment were 120 min for N. melanoleuca and N. nigricollis venoms and their toxins and 240 min for N. nivea and N. haje venoms and their toxins. Steady-state distribution between the shallow tissue compartment and the blood gave values of 0.50 and 0.92 (N. melanoleuca), 1.64 and 1.05 (N. nivea), 0.78 and 0.92 (N. nigricollis) and 1.70 and 1.03 (N. haje) for the venoms and their toxins, respectively. The corresponding values for the deep tissue compartment gave ratios of 3.31 and 3.44 (N. melanoleuca), 2.99 and 1.68 (N. nivea), 3.74 and 3.79 (N. nigricollis) and 1.39 and 2.46 (N. haje) for the venoms and their toxins, respectively. Ratios lower than unity indicate lower venom and toxin concentrations in the tissues than in the blood, while larger ratios denote higher tissue concentrations. The values thus reflect a higher affinity of the venoms and their toxins for the central than the shallow tissue compartment and for the deep tissue than the central compartment. The sites of action of the venoms seem to be located in the deep tissue compartment since most of the pharmacological, biochemical and electrocardiographic effects of the venoms started 30-60 min after i.v. injection. The mean residence time in the body, MRTb, ranged from 20.8 to 51.8 hr, which correlated well with the long duration of the pharmacological and biochemical effects induced by the venoms. The tissue distribution of the venoms and toxins was similar, with the highest uptake being in the kidneys, followed by the stomach, lungs, liver, spleen, intestine, heart and diaphragm. Very high radioactivity was found in the stomach contents, which reached values higher than the kidneys. Some of the biochemical markers were significantly changed by one or more venoms but the grouped parameters did not reflect significant changes in cardiac, renal, hepatic or electrolyte profiles as a function of time. It is concluded that antivenom, even if injected several hours after a cobra bite, is still capable of neutralizing the slowly eliminating venom. To speed up neutralization of the venom effects, doses of antivenom higher than the calculated in vitro neutralizing dose ought to be injected to compensate for the slow rate of transfer of antivenom to the tissues.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8896193     DOI: 10.1016/0041-0101(96)00055-4

Source DB:  PubMed          Journal:  Toxicon        ISSN: 0041-0101            Impact factor:   3.033


  9 in total

1.  Durable pharmacological responses from the peptide ShK-186, a specific Kv1.3 channel inhibitor that suppresses T cell mediators of autoimmune disease.

Authors:  Eric J Tarcha; Victor Chi; Ernesto J Muñoz-Elías; David Bailey; Luz M Londono; Sanjeev K Upadhyay; Kayla Norton; Amy Banks; Indra Tjong; Hai Nguyen; Xueyou Hu; Greg W Ruppert; Scott E Boley; Richard Slauter; James Sams; Brian Knapp; Dustin Kentala; Zachary Hansen; Michael W Pennington; Christine Beeton; K George Chandy; Shawn P Iadonato
Journal:  J Pharmacol Exp Ther       Date:  2012-05-25       Impact factor: 4.030

2.  Histological, molecular and biochemical detection of renal injury after Echis pyramidum snake envenomation in rats.

Authors:  Awadh M Al-Johany; Mohamed K Al-Sadoon; Ahmed E Abdel Moneim; Amira A Bauomy; Marwa S M Diab
Journal:  Saudi J Biol Sci       Date:  2014-10-23       Impact factor: 4.219

3.  Pharmacokinetics of Naja sumatrana (equatorial spitting cobra) venom and its major toxins in experimentally envenomed rabbits.

Authors:  Michelle Khai Khun Yap; Nget Hong Tan; Si Mui Sim; Shin Yee Fung; Choo Hock Tan
Journal:  PLoS Negl Trop Dis       Date:  2014-06-05

Review 4.  Diagnosis of snakebite and the importance of immunological tests in venom research.

Authors:  R David G Theakston; Gavin D Laing
Journal:  Toxins (Basel)       Date:  2014-05-23       Impact factor: 4.546

5.  Compositional and toxicological investigation of pooled venom from farm-raised Naja atra.

Authors:  Gang Xiao; Junqi Liu; Lingfeng Peng; Yang Yang; Zhiliang Sun
Journal:  J Venom Anim Toxins Incl Trop Dis       Date:  2022-03-14

6.  Non-compartmental toxicokinetic studies of the Nigerian Naja nigricollis venom.

Authors:  Auwal A Bala; Sani Malami; Yusuf Abubakar Muhammad; Binta Kurfi; Ismaila Raji; Sanusi Muhammad Salisu; Mustapha Mohammed; George Oche Ambrose; Murtala Jibril; Jacob A Galan; Elda E Sanchez; Basheer A Z Chedi
Journal:  Toxicon X       Date:  2022-04-01

7.  Production of the first effective hyperimmune equine serum antivenom against Africanized bees.

Authors:  Keity Souza Santos; Marco Antonio Stephano; José Roberto Marcelino; Virginia Maria Resende Ferreira; Thalita Rocha; Celso Caricati; Hisako Gondo Higashi; Ana Maria Moro; Jorge Elias Kalil; Osmar Malaspina; Fabio Fernandes Morato Castro; Mário Sérgio Palma
Journal:  PLoS One       Date:  2013-11-13       Impact factor: 3.240

Review 8.  Pharmacokinetics of Snake Venom.

Authors:  Suchaya Sanhajariya; Stephen B Duffull; Geoffrey K Isbister
Journal:  Toxins (Basel)       Date:  2018-02-07       Impact factor: 4.546

9.  pH-sensitive dual drug loaded janus nanoparticles by oral delivery for multimodal analgesia.

Authors:  Lin Liu; Wendong Yao; Xiaowei Xie; Jianqing Gao; Xiaoyang Lu
Journal:  J Nanobiotechnology       Date:  2021-08-06       Impact factor: 10.435

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.